MarginsXMarginsX
Home › Markets › Industrials › RPID

Rapid Micro Biosystems Inc. (RPID)

RPID trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.7400
+13.67% on the day
Market cap
$37.1M
Nano cap
Revenue · 2025
$33.6M
+19.7% on 2024
Net income · 2025
-$47.1M
-140.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/0001380106-26-000034-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerRPID on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2021
SEC CIK0001380106
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$33.6M
Net income-$47.1M
Operating income-$47.4M
Net margin-140.3%
Operating margin-141.1%
Revenue growth+19.7%
Cash$20.0M
Total assets$74.9M
P/E (computed)Net income was not positive
P/S (computed)1.1×

Warning signs

Cash runway
4.4 months
$14.7M cash at June 30, 2026
Share count, 1 year
+13.5%
2025-07-31 to 2026-07-31
Going-concern doubt
No
10-Q filed August 7, 2026
Insider net buying, 12 months
-$1.1M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-07
Cash and burn$14.7M cash; operating cash flow -$10.0M a quarter.Report 2026-06-30
Shares outstanding50,159,556 (2026-07-31); 44,210,328 a year earlier.Cover page 2026-07-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-05-19
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $1.1M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$8.1M-$12.9M-$12.7M$14.7M$19.1M$35.2M10-Q 2026-08-07
Q1 2026
2026-03-31
$8.0M-$14.3M-$15.1M$13.8M$19.1M$34.4M10-Q 2026-05-15
Q4 2025
2025-12-31
$11.3M-$12.5M-$3.2M$20.0M$18.9M$33.6M10-K 2026-03-12
Q3 2025
2025-09-30
$7.8M-$11.5M-$9.1M$18.9M$18.8M$30.5M10-Q 2025-11-07
Q2 2025
2025-06-30
$7.3M-$11.9M-$9.7M$18.3MNo debt tags$30.3M10-Q 2026-08-07
Q1 2025
2025-03-31
$7.2M-$11.3M-$9.1M$18.9MNo debt tags$29.6M10-Q 2026-05-15
Q4 2024
2024-12-31
$8.2M-$9.7M-$9.9M$16.9M$0$28.1M10-K 2026-03-12
Q3 2024
2024-09-30
$7.6M-$11.3M-$8.6M$22.0MNo debt tags$26.2M10-Q 2025-11-07

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-05-19
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-08-07
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-08

Source: SEC EDGAR submissions feed, 329 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.6%
1 month-25.5%
3 months-61.7%
Year to date-77.6%
1 year-85.4%
From 52-week high-86.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
PRPOPrecipio Inc.$19.96-9.81%$35.8M
EYPTEyePoint Inc.$0.3076+0.52%$35.0M
HBIOHarvard Bioscience Inc.$8.91-5.96%$40.7M
CIRCCircle8 Group Inc.$0.1702-7.30%$20.0M
SEERSeer Inc.$1.48-5.73%$82.6M
BNGOBionano Genomics Inc.$0.9400-6.00%$13.1M
QTRXQuanterix Corporation$2.84-3.07%$134.8M
ASTCAstrotech Corporation (DE)$3.76-10.48%$8.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier